AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2011
Aug 9, 2011
35124_dirs_2011-08-09_21d1e4f1-a2b5-4ebd-9b82-6bf77c1533e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-08-09
Reporting Person: LINK MAX (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-09 | Celsion Corporation Common Stock | C | 17083 | $2.4 | Acquired | 261025 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-08-09 | Series A 8% Redeemable Convertible Preferred Stock | $2.4 | C | 41 | Acquired | 2013-01-14 | Celsion Corporation Common Stock (17083) | Direct |
Footnotes
F1: Shares of Series A 8% Redeemable Convertible Preferred Stock with a stated value of $1,000 were converted into shares of Celsion Corporation Common Stock at a fixed conversion price of $2.40 per common share.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23